| pubmed-article:21342170 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21342170 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21342170 | lifeskim:mentions | umls-concept:C1556095 | lld:lifeskim |
| pubmed-article:21342170 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:21342170 | lifeskim:mentions | umls-concept:C0001144 | lld:lifeskim |
| pubmed-article:21342170 | lifeskim:mentions | umls-concept:C0205462 | lld:lifeskim |
| pubmed-article:21342170 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:21342170 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:21342170 | lifeskim:mentions | umls-concept:C1378128 | lld:lifeskim |
| pubmed-article:21342170 | lifeskim:mentions | umls-concept:C0286402 | lld:lifeskim |
| pubmed-article:21342170 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:21342170 | pubmed:dateCreated | 2011-2-23 | lld:pubmed |
| pubmed-article:21342170 | pubmed:abstractText | Nadifloxacin is a fluoroquinolone with broad-spectrum antibacterial activity. Although it is used as an acne treatment in some European countries, it has not been used to treat Korean acne patients. We aimed to evaluate the clinical efficacy and safety of 1% nadifloxacin cream and the histological changes it incurs when used to treat mild to moderate facial acne in Korean patients. | lld:pubmed |
| pubmed-article:21342170 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21342170 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21342170 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21342170 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21342170 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21342170 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21342170 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21342170 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21342170 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:21342170 | pubmed:issn | 1365-4632 | lld:pubmed |
| pubmed-article:21342170 | pubmed:author | pubmed-author:SuhDae HunDH | lld:pubmed |
| pubmed-article:21342170 | pubmed:author | pubmed-author:YoonMi... | lld:pubmed |
| pubmed-article:21342170 | pubmed:author | pubmed-author:JungJae... | lld:pubmed |
| pubmed-article:21342170 | pubmed:author | pubmed-author:KwonHyuck... | lld:pubmed |
| pubmed-article:21342170 | pubmed:author | pubmed-author:YeomKkot... | lld:pubmed |
| pubmed-article:21342170 | pubmed:copyrightInfo | © 2011 The International Society of Dermatology. | lld:pubmed |
| pubmed-article:21342170 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21342170 | pubmed:volume | 50 | lld:pubmed |
| pubmed-article:21342170 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21342170 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21342170 | pubmed:pagination | 350-7 | lld:pubmed |
| pubmed-article:21342170 | pubmed:meshHeading | pubmed-meshheading:21342170... | lld:pubmed |
| pubmed-article:21342170 | pubmed:meshHeading | pubmed-meshheading:21342170... | lld:pubmed |
| pubmed-article:21342170 | pubmed:meshHeading | pubmed-meshheading:21342170... | lld:pubmed |
| pubmed-article:21342170 | pubmed:meshHeading | pubmed-meshheading:21342170... | lld:pubmed |
| pubmed-article:21342170 | pubmed:meshHeading | pubmed-meshheading:21342170... | lld:pubmed |
| pubmed-article:21342170 | pubmed:meshHeading | pubmed-meshheading:21342170... | lld:pubmed |
| pubmed-article:21342170 | pubmed:meshHeading | pubmed-meshheading:21342170... | lld:pubmed |
| pubmed-article:21342170 | pubmed:meshHeading | pubmed-meshheading:21342170... | lld:pubmed |
| pubmed-article:21342170 | pubmed:meshHeading | pubmed-meshheading:21342170... | lld:pubmed |
| pubmed-article:21342170 | pubmed:meshHeading | pubmed-meshheading:21342170... | lld:pubmed |
| pubmed-article:21342170 | pubmed:meshHeading | pubmed-meshheading:21342170... | lld:pubmed |
| pubmed-article:21342170 | pubmed:meshHeading | pubmed-meshheading:21342170... | lld:pubmed |
| pubmed-article:21342170 | pubmed:meshHeading | pubmed-meshheading:21342170... | lld:pubmed |
| pubmed-article:21342170 | pubmed:meshHeading | pubmed-meshheading:21342170... | lld:pubmed |
| pubmed-article:21342170 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21342170 | pubmed:articleTitle | Clinical and histological evaluation of 1% nadifloxacin cream in the treatment of acne vulgaris in Korean patients. | lld:pubmed |
| pubmed-article:21342170 | pubmed:affiliation | Department of Dermatology, Seoul National University College of Medicine, Seoul, South Korea. | lld:pubmed |
| pubmed-article:21342170 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21342170 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
